Where is Embera headquartered?

Embera is located in Sudbury, MA.

Who invested in Embera?

Embera has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for Embera?

Embera closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

emberaneuro.com

Embera

Embera is a biotechnology company that develops drugs for nicotine addiction and neurodegenerative diseases.

Business Model:

Revenue: $1.5M

Employees: 11-50

Rankings

Industries / Tags:

Pharmaceuticals & Biotechnology

Biotechnology

Medical Device

Therapeutics

Detailed Embera Information

General Information

Geographic Data

Address: 365 Boston Post Rd.

City: Sudbury

State: MA

Zip: 01776

Country: US

Financial Info

Stage:

series a

Raised Last:

$1M

Raised Total:

$28M

Social

Facebook

Crunchbase

Metrics

5,851,699Website Global Rank

1,416Website Monthly Traffic

Twitter Followers

Description

Embera is a biotechnology company that develops drugs for nicotine addiction and neurodegenerative diseases.

Contact Phone:
+19785794156

Contact Email:

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
12/2019	Series B		$0	Keiretsu Capital Keiretsu Capital
8/2016	Venture Round	1	-	Keiretsu Capital Keiretsu Capital
2/2015	Series A		$0	HRA Pharma Louisiana Funds BVM Capital Keiretsu Capital Keiretsu Forum Northwest HRA Pharma Louisiana Funds BVM Capital Keiretsu Capital Keiretsu Forum Northwest
12/2019	Grant	2	-	National Institute on Drug Abuse (NIDA) Rose Research Center (RRC) in North Carolina National Institute on Drug Abuse (NIDA) Rose Research Center (RRC) in North Carolina
9/2015	Venture Round	1	$2M	Keiretsu Capital Keiretsu Capital
3/2010	Series A		$490k
1/2016	Venture Round	1	-	Keiretsu Capital Keiretsu Capital
12/2014	Equity		$4.5M
2/2007	Series A	1	$800k	Louisiana Ventures Louisiana Ventures
7/2014	Grant		-
2/2021	Series A		$0	Innovation Catalyst Innovation Catalyst
12/2019	Series B		-
4/2015	Series A		$2M	HRA Pharma
12/2019	Grant		$11.1M	National Institute on Drug Abuse of the National Institutes of Health Foundation for a Smoke-Free World
9/2019	Equity		$6.1M
1/2020	Venture Round		-
8/2011	Series A		$0	Louisiana Funds Themelios Ventures Louisiana Ventures Louisiana Funds Themelios Ventures Louisiana Ventures
5/2009	Venture Round		$400k
11/2009	Seed Round		$100k
2/2006	Venture Round		$800k
9/2008	Venture Round	2	$300k	Themelios Ventures Louisiana Ventures Themelios Ventures Louisiana Ventures
7/2016	Grant	2	$11M	Keiretsu Capital National Institutes of Health Keiretsu Capital National Institutes of Health
12/2019	Series B		-	National Institute on Drug Abuse of the National Institutes of Health Foundation for a Smoke-Free World National Institute on Drug Abuse of the National Institutes of Health Foundation for a Smoke-Free World
2/2021	Series A	1	$1.3M	Innovation Catalyst Innovation Catalyst
1/2020	Venture Round		-
12/2019	Grant	2	-	National Institute on Drug Abuse (NIDA) Rose Research Center (RRC) in North Carolina National Institute on Drug Abuse (NIDA) Rose Research Center (RRC) in North Carolina
12/2019	Series B	1	$4.4M	Keiretsu Capital Keiretsu Capital
8/2016	Venture Round	1	-	Keiretsu Capital Keiretsu Capital
1/2016	Venture Round	1	-	Keiretsu Capital Keiretsu Capital
2/2015	Series A	5	$2.3M	HRA Pharma HRA Pharma
7/2014	Grant		-

Acquisitions

Announced Date	Name	Price

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details